• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎中常规采集的患者报告结局测量的应用。

The use of routinely collected patient-reported outcome measures in rheumatoid arthritis.

机构信息

Department of Health Services Research, Care and Public Health Research Institute, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands.

Department of Health Services Research, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands.

出版信息

Semin Arthritis Rheum. 2018 Dec;48(3):357-366. doi: 10.1016/j.semarthrit.2018.03.006. Epub 2018 Mar 15.

DOI:10.1016/j.semarthrit.2018.03.006
PMID:29709290
Abstract

This study systematically reviewed commonly used patient-reported outcome measures (PROMs) for rheumatoid arthritis (RA), routinely collected in clinical practice, and evaluated objectives of their use. An additional survey conducted among identified RA registries provided additional information about collection of PROMs. Medline Ovid and Embase were searched for observational studies using data of RA registries/cohorts, published between 2011 and 2016. The search combined a validated search algorithm for PROMs and RA. Study characteristics, objective, registry, country, type of PROMs collected, and time interval of collection were systematically recorded. The survey asked about PROMs collected by the registries, timing, response rates, and barriers to collection. Ninety-eight articles from 15 countries were identified making use of 37 registries and large cohorts. Thirty-three PROMs were collected routinely, with VAS, EQ-5d and HAQ being the most used tools. Health domains reported the most were functional assessment, pain and patient global assessment. Despite the wide variety of collected PROMs, foci of the articles were similar and reported results narrow. This review suggests rethinking the role of PROMs in rheumatology research to use this information as broadly as possible, including evaluation of treatments, economic analyses, and decision-making based on patients' experiences at system, provider, and physician level.

摘要

本研究系统地回顾了类风湿关节炎(RA)临床实践中常用的、常规收集的患者报告结局测量(PROMs),并评估了其使用目的。在确定的 RA 登记处中进行的额外调查提供了关于 PROMs 收集的更多信息。在 2011 年至 2016 年期间,使用 RA 登记处/队列的数据,在 Medline Ovid 和 Embase 上搜索观察性研究。该搜索结合了用于 PROMs 和 RA 的验证搜索算法。系统地记录了研究特征、目的、登记处、国家、收集的 PROM 类型以及收集的时间间隔。该调查询问了登记处收集的 PROMs、时间安排、应答率以及收集障碍。来自 15 个国家的 98 篇文章利用 37 个登记处和大型队列进行了研究。33 种 PROMs 被常规收集,VAS、EQ-5d 和 HAQ 是最常用的工具。报告的健康领域主要是功能评估、疼痛和患者整体评估。尽管收集的 PROMs 种类繁多,但文章的重点相似,报告的结果也很有限。本综述建议重新思考 PROMs 在风湿病学研究中的作用,以便尽可能广泛地利用这些信息,包括对治疗的评估、经济分析以及基于患者在系统、提供者和医生层面的经验做出决策。

相似文献

1
The use of routinely collected patient-reported outcome measures in rheumatoid arthritis.类风湿关节炎中常规采集的患者报告结局测量的应用。
Semin Arthritis Rheum. 2018 Dec;48(3):357-366. doi: 10.1016/j.semarthrit.2018.03.006. Epub 2018 Mar 15.
2
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.阿达木单抗、依那西普、英夫利昔单抗、聚乙二醇化赛妥珠单抗、戈利木单抗、托珠单抗和阿巴西普用于治疗既往未使用改善病情抗风湿药物治疗且仅在传统改善病情抗风湿药物治疗失败后的类风湿关节炎:系统评价和经济学评估。
Health Technol Assess. 2016 Apr;20(35):1-610. doi: 10.3310/hta20350.
3
Outcomes Reported in Prospective Long-Term Observational Studies and Registries of Patients With Rheumatoid Arthritis Worldwide: An Outcome Measures in Rheumatology Systematic Review.全球类风湿关节炎患者前瞻性长期观察研究和登记处的报告结果:风湿病学结局测量的系统评价。
Arthritis Care Res (Hoboken). 2021 May;73(5):649-657. doi: 10.1002/acr.24163.
4
Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study.类风湿关节炎中,巴瑞替尼与安慰剂或阿达木单抗对比的3期研究的患者报告结局:RA-BEAM研究的二次分析
Ann Rheum Dis. 2017 Nov;76(11):1853-1861. doi: 10.1136/annrheumdis-2017-211259. Epub 2017 Aug 10.
5
Treat-to-target in rheumatoid arthritis: Evaluating the patient perspective using the Patient Opinion Real-Time Anonymous Liaison system: The RA T2T PORTAL study.目标治疗类风湿关节炎:使用患者意见实时匿名联络系统评估患者观点:RA T2T PORTAL 研究。
Int J Rheum Dis. 2019 May;22(5):874-879. doi: 10.1111/1756-185X.13514. Epub 2019 Feb 22.
6
Gain in quality-adjusted life-years in patients with rheumatoid arthritis during 1 year of biological therapy: a prospective study in clinical practice.生物治疗 1 年内类风湿关节炎患者的质量调整生命年获益:临床实践中的前瞻性研究。
J Rheumatol. 2013 Sep;40(9):1479-86. doi: 10.3899/jrheum.121387. Epub 2013 Jul 1.
7
An Early Rheumatoid Arthritis Treatment Evaluation Registry (ERATER) in the United States.美国的一个早期类风湿性关节炎治疗评估登记处(ERATER)。
Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S178-81.
8
Long-term outcomes of patients who rate symptoms of rheumatoid arthritis as 'satisfactory'.将类风湿性关节炎症状评为“满意”的患者的长期预后。
Rheumatology (Oxford). 2020 Aug 1;59(8):1853-1861. doi: 10.1093/rheumatology/kez497.
9
The Reporting of Patient-reported Outcomes in Studies of Patients with Rheumatoid Arthritis: A Systematic Review of 250 Articles.类风湿关节炎患者研究中患者报告结局的报告:对250篇文章的系统评价
J Rheumatol. 2016 Jul;43(7):1300-5. doi: 10.3899/jrheum.151177. Epub 2016 Apr 15.
10
Impact of rituximab on patient-reported outcomes in patients with rheumatoid arthritis from the US Corrona Registry.来自美国 Corrona 注册研究的利妥昔单抗对类风湿关节炎患者报告结局的影响。
Clin Rheumatol. 2017 Sep;36(9):2135-2140. doi: 10.1007/s10067-017-3742-2. Epub 2017 Jul 17.

引用本文的文献

1
Investigation of the Effectiveness of a Biopsychosocial-Based Exercise Approach in Rheumatic Diseases: A Mixed Methods Research With Patients' Perspectives.基于生物心理社会的运动方法在风湿性疾病中的有效性调查:一项基于患者视角的混合方法研究
J Eval Clin Pract. 2025 Feb;31(1):e70033. doi: 10.1111/jep.70033.
2
Correlation between disease activity and patient-reported health-related quality of life in rheumatoid arthritis: a cross-sectional study.类风湿关节炎患者疾病活动度与健康相关生存质量的相关性:一项横断面研究。
BMJ Open. 2024 May 2;14(5):e082020. doi: 10.1136/bmjopen-2023-082020.
3
Concordance and agreement between different activity scores in polymyalgia rheumatica.
多发性肌痛症不同活动评分之间的一致性和吻合度。
RMD Open. 2024 Mar 15;10(1):e003741. doi: 10.1136/rmdopen-2023-003741.
4
Patient-Reported Outcome Measures for Patients with Upper Extremity Arthritis: Overview of Systematic Reviews.上肢关节炎患者的患者报告结局测量:系统评价概述
Clin Med Insights Arthritis Musculoskelet Disord. 2023 Dec 6;16:11795441231213887. doi: 10.1177/11795441231213887. eCollection 2023.
5
Refractory inflammatory arthritis definition and model generated through patient and multi-disciplinary professional modified Delphi process.通过患者和多学科专业人员修改后的德尔菲流程生成的难治性炎症性关节炎定义和模型。
PLoS One. 2023 Aug 9;18(8):e0289760. doi: 10.1371/journal.pone.0289760. eCollection 2023.
6
Modulation of Pain Sensitivity by a Hyperventilatory Breathing Exercise and Cold Exposure Training.通过过度通气呼吸练习和冷暴露训练调节疼痛敏感性
J Pain Res. 2023 Jun 13;16:1979-1991. doi: 10.2147/JPR.S400408. eCollection 2023.
7
Selecting patient-reported outcome measures of health-related quality of life in adult rheumatology: quality and breadth of coverage.选择成人风湿病中患者报告的健康相关生活质量结局指标:覆盖范围的质量和广度。
Rheumatol Int. 2023 Apr;43(4):627-638. doi: 10.1007/s00296-022-05200-6. Epub 2022 Sep 20.
8
Baseline health-related quality of life predicts falls: a secondary analysis of a randomized controlled trial.基线健康相关生活质量预测跌倒:一项随机对照试验的二次分析。
Qual Life Res. 2022 Nov;31(11):3211-3220. doi: 10.1007/s11136-022-03175-2. Epub 2022 Jul 7.
9
Improvement in RAID questionnaire results in patients with rheumatoid arthritis treated with advanced therapies.接受高级治疗的类风湿关节炎患者的 RAID 问卷结果得到改善。
Eur J Hosp Pharm. 2023 Dec 27;31(1):21-26. doi: 10.1136/ejhpharm-2021-003084.
10
Electronic patient-reported outcome measures using mobile health technology in rheumatology: A scoping review.电子患者报告结局测量在风湿病学中使用移动医疗技术:范围综述。
PLoS One. 2021 Jul 22;16(7):e0253615. doi: 10.1371/journal.pone.0253615. eCollection 2021.